Avant Diagnostics, Inc Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense
Avant Diagnostics, Inc reported Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense of $1.37 million for the 12-month period ending 2014-09-30, per its 10-K filed 2016-01-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense · last filed 2016-01-13
- Avant Diagnostics, Inc deferred compensation arrangement with individual, allocated share-based compensation expense for fiscal 2014 was $1.37M.
| Period end | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense 12 month |
|---|---|
| 2014-09-30 | $1.37M 10-K · filed 2016-01-13 |